Surgical Treatment for ODS With Rectal Prolapse Surgical Treatment for Rectal Prolapse

NCT ID: NCT03487640

Last Updated: 2022-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-08

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstinate constipation is hard to deal with in clinic. Especially for obstructed defecation syndrome(ODS). Rectal prolapse is the most common type of ODS. Lots of surgical procedures have been suggested for it but with unsatisfactory results.To develop new surgical treatment and to provide higher quality proof for this intractable condition is of significance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation by Outlet Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transanal rectal mucosa resection

TARMR: Transanal resection of rectal mucosa for at least 5cm in length.

TARMR

Intervention Type PROCEDURE

Transanal resection of rectal mucosa for at least 5cm in length.

Laparoscopic rectal suspension and colectomy

LARSC: We are going to suspend the rectum and to resect rigmarole hidgut Laparoscopically

LARSC

Intervention Type PROCEDURE

We are going to suspend the rectum and to resect rigmarole hidgut Laparoscopically

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TARMR

Transanal resection of rectal mucosa for at least 5cm in length.

Intervention Type PROCEDURE

LARSC

We are going to suspend the rectum and to resect rigmarole hidgut Laparoscopically

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with ODS by defecography, coloscopy, barium enema and dynamic MRI.
* Patients should accord with Rome IV criteria.

Exclusion Criteria

* Severe heart or other organ disease.
* test.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Third Military Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Weidong Tong

Third Military Medical University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yong Yang, Dr.

Role: STUDY_CHAIR

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Weidong Tong

Yuzhong, Chongqing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LarTARP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.